| 28 |
[2019.07.15] Interview with the CEO of CUBEBIO, "We are expecting an early cancer treatment through the cancer self-diagnositc program"
|
cubebio |
2019-07-23 |
982 |
|
| 27 |
[2019.04.16] CUBEBIO signs a contract with Samsung Securities Co., Ltd as a lead underwriter for KOSDAQ listings
|
cubebio |
2019-07-23 |
923 |
|
| 26 |
[2019.02.18] CUBEBIO obtains permission for sales of in vitro diagnostics in China
|
cubebio |
2019-07-23 |
888 |
|
| 25 |
[2019.01.29] CUBEBIO signs a contract with a China-based large asset management company with regards to NASDAQ listings
|
cubebio |
2019-07-23 |
936 |
|
| 24 |
[2019.01.15] CUBEBIO gains permission for cancer diagnostic devices from the FDA of the Philippines
|
cubebio |
2019-07-23 |
862 |
|
| 23 |
[2019.01.08] CUBEBIO is awarded the Korean Patent Grand Prize
|
cubebio |
2019-07-23 |
815 |
|
| 22 |
[2019.01.03] Identifying existence of tumor cells at an early stage through the analysis of urine
|
cubebio |
2019-07-23 |
800 |
|
| 21 |
[2018.12.27] CUBEBIO signs a strategic cooperation agreement for IPO in Hong Kong
|
cubebio |
2019-07-23 |
1736 |
|
| 20 |
[2018.12.20] CUBEBIO attracts an investment worth KRW 30 billion from Cybernaut, a Chiense
|
cubebio |
2019-07-23 |
1556 |
|
| 19 |
[2018.12.24] CUBEBIO signs a contract with a law firm, JIPYONG, and others for consultation about Asian market entry and listing
|
cubebio |
2019-07-23 |
885 |
|